Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Advanced Cancer × Niacin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Psychotherapy 1 Niacin 1 Mirtazapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05398484 2025-12-04

Psilocybin Therapy in Advanced Cancer

NYU Langone Health

Phase 2/3 Recruiting

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡